Zusammenfassung
Hintergrund
Adenosin reguliert durch die Aktivierung seiner Rezeptoren zahlreiche physiologische Prozesse, z. B. eine Zytoprotektion bei Ischämie/Hypoxie sowie die Kammerwassersekretion und damit den Augeninnendruck. Wir untersuchten die Expression der Rezeptorisoformen in Augen mit PEX-Syndrom, das mit einer ausgeprägten Vorderkammerhypoxie und erhöhtem Augeninnendruck assoziiert ist.
Material und Methoden
Die mRNA- und Proteinexpression der Adenosinrezeptorsubtypen in okulären Geweben von Patienten mit PEX-Syndrom, Glaukomen und normalen Augen wurden vergleichend analysiert.
Ergebnisse
Während die Rezeptorsubtypen A1, A2a und A2b keine Expressionsunterschiede zwischen PEX- und Kontrollgeweben zeigten, war die Expression des A3-Adenosinrezeptors im unpigmentierten Ziliarepithel aller PEX-Augen, unabhängig vom Vorhandensein eines Glaukoms, im Vergleich mit normalen und glaukomatösen Kontrollaugen signifikant erhöht.
Schlussfolgerung
Die in der Vorderkammer von PEX-Augen vorliegenden Stressbedingungen scheinen zu einer selektiven Induktion der A3-Rezeptorexpression im Ziliarepithel zu führen. Der A3-Adenosinrezeptor könnte als potenzielles Targetmolekül für neue Therapieansätze bei PEX-Patienten dienen.
Abstract
Background
Adenosine regulates many physiologic processes, such as aqueous humor secretion and intraocular pressure, via activation of its receptors. We investigated the expression of the receptor isoforms in eyes with PEX syndrome, which is associated with anterior chamber hypoxia and elevated intraocular pressure.
Materials and methods
The mRNA and protein expression of the adenosine receptor subtypes in anterior segment tissues of patients with PEX syndrome, glaucomas, and normal control eyes were analyzed comparatively.
Results
Whereas the receptor subtypes A1, A2a, and A2b displayed no differential expression between PEX and control tissues, expression of the A3 adenosine receptor was consistently enhanced in the nonpigmented ciliary epithelium of all PEX eyes, independent of the presence of glaucoma, compared to normal and glaucomatous control eyes.
Conclusion
Considering the known role of the A3 adenosine receptor in modulating aqueous humor secretion, its selective upregulation in the ciliary epithelium may confer cytoprotection and be accessible to therapeutic intervention in PEX patients.
Literatur
Avila MY, Stone RA, Civan MM (2001) A1-, A2A- and A3-subtype adenosine receptors modulate intraocular pressure in the mouse. Br J Pharmacol 134: 241–245
Avila MY, Stone RA, Civan MM (2002) Knockout of A3 adenosine receptors reduces mouse intraocular pressure. Invest Ophthalmol Vis Sci 43: 3021–3026
Braunagel SC, Xiao JG, Chiou GC (1988) The potential role of adenosine in regulating blood flow in the eye. J Ocular Pharm 4: 61–73
Bruns RF (1990) Adenosine receptors: roles and pharmacology. Ann NY Acad Sci 603: 211–225
Carre DA, Mitchell CH, Peterson-Yantorno K, Coca-Prados M, Civan MM (1997) Adenosine stimulates Cl− channels of nonpigmented ciliary epithelial cells. Am J Physiol 273: C1354–C1361
Civan MM (2003) The fall and rise of active chloride transport: implications for regulation of intraocular pressure. J Exp Zool 300A: 5–13
Crosson CE (1995) Adenosine receptor activation modulates intraocular pressure in rabbits. J Pharmacol Exp Ther 273: 320–326
Crosson CE, Gray T (1996) Characterization of ocular hypertension induced by adenosine agonists. Invest Ophthalmol Vis Sci 37: 1833–1839
Daines BS, Kent AR, McAleer MS, Crosson CE (2003) Intraocular adenosine levels in normal and ocular hypertensive patients. J Ocular Pharmacol Ther 19: 113–119
Fleischhauer JC, Mitchell CH, Stamer WD, Karl MO, Peterson-Yantorno K, Civan MM (2003) Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport. J Membr Biol 193: 121–136
Fredholm BB, Ijzerman AP, Jacobson KA, Klotz K-N, Linden J (2001) Nomenclature and classification of adenosine receptors. Pharm Rev 53: 527–552
Gregory CY, Abrams TA, Hall MO (1994) Stimulation of A2 adenosine receptors inhibits the ingestion of photoreceptor outer segments by retinal pigment epithelium. Invest Ophthalmol Vis Sci 35: 819–825
Helbig H, Schlötzer-Schrehardt U, Noske W, Kellner U, Foerster MH, Naumann GO (1994) Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. German J Ophthalmol 3: 148–153
Johnson DH, Brubaker RF (1982) Dynamics of aqueous humor in the syndrome of exfoliation with glaucoma. Am J Ophthalmol 93: 629–634
Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Hollo G, Katsimbris IE, Georgiadis N, Ritch R (2003) 8-isoprostaglandin F2A and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 87: 353–356
Kvanta A, Seregard S, Sejersen S, Kull B, Fredholm BB (1997) Localization of adenosine receptor messenger RNAs in the rat eye. Exp Eye Res 65: 595–602
Larsen AK, Osbourne NN (1996) Involvement of adenosine in retinal ischemia. Studies on rat. Invest Ophthalmol Vis Sci 37: 2603–2611
Lutty GA, McLeod DS (2003) Retinal vascular development and oxygen-induced retinopathy: a role for adenosine. Progr Ret Eye Res 22: 95–111
Macaluso C, Frishman LJ, Frueh B, Kaelin-Lang A, Onoe S, Niemeyer G (2003) Multiple effects of adenosine in the arterially perfused mammalian eye. Possible mechanisms for the neuroprotective function of adenosine in the retina. Doc Ophthalmol 106: 51–59
Mitchell CH, Peterson-Yantorno K, Carre DA, McGlinn AM, Coca-Prados M, Stone RA, Civan MM (1999) A3 adenosine receptors regulate Cl− channels of nonpigmented ciliary epithelial cells. Am J Physiol 276: C659–C666
Naumann GO, Schlötzer-Schrehardt U, Küchle M (1998) Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmology 105: 951–968
Okamura T, Kurogi Y, Hashimoto K, Sato S, Nishikawa H, Kiryu K, Nagao Y (2004) Structure-activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucoma. Bioorg Med Chem Lett 14: 3775–3779
Polska E, Ehrlich P, Luksch AQ, Fuchsjäger-Mayrl G, Schmetterer L (2003) Effects of adenosine on intraocular pressure, optic nerve head blood flow, and choroidal blood flow in healthy humans. Invest Ophthalmol Vis Sci 44: 3110–3114
Portellos M, Riva CE, Cranstoun SD, Petrig BL, Brucker AJ (1995) Effects of adenosine on ocular blood flow. Invest Ophthalmol Vis Sci 36: 1904–1909
Ramkumar V, Hallam DM, Nie Z (2001) Adenosine, oxidative stress and cytoprotection. Jpn J Pharmacol 86: 265–274
Riley MV, Winkler BS, Starnes CA, Peters MI (1996) Adenosine promotes regulation of corneal hydration through cyclic adenosine monophosphate. Invest Ophthalmol Vis Sci 37: 1–10
Roth S, Rosenbaum PS, Osinski J, Park SS, Toledano AY, Li B, Moshfeghi AA (1997) Ischemia induces significant changes in purine nucleoside concentration in the retina-choroid in rats. Exp Eye Res 65: 771–779
Schlötzer-Schrehardt U, Zenkel M, Hofmann-Rummelt C, Naumann GO (2004) The A3 adenosine receptor is upregulated in eyes with pseudoexfoliation syndrome and glaucoma. Invest Ophthalmol Vis Sci 45: E-Abstract 3535
Sen HA, Campochiaro PA (1989) Intravitreous injection of adenosine or its agonists causes breakdown of the blood-retinal barrier. Arch Ophthalmol 107: 1364–1367
Tian B, Gabelt BT, Crosson CE, Kaufman PL (1997) Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys. Exp Eye Res 64: 979–989
Wax M, Sanghavi DM, Lee CH, Kapadia M (1993) Purinergic receptors in ocular ciliary epithelial cells. Exp Eye Res 57: 89–95
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schlötzer-Schrehardt, U., Zenkel, M., Hofmann-Rummelt, C. et al. Funktionelle Bedeutung der Adenosinrezeptoren im Auge und ihre Dysregulation beim Pseudoexfoliationssyndrom. Ophthalmologe 102, 1074–1082 (2005). https://doi.org/10.1007/s00347-005-1216-4
Issue Date:
DOI: https://doi.org/10.1007/s00347-005-1216-4
Schlüsselwörter
- Adenosinrezeptoren
- A3-Adenosinrezeptor
- Pseudoexfoliationssyndrom
- Pseudoexfoliationsglaukom
- Ziliarepithel